EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes

Shuai Xu, Chao Han, Jian Zhou, Di Yang, Hui Dong, Yiwei Zhang, Tingting Zhao, Yi Tian, Yuzhang Wu

Cancer Immunology, Immunotherapy · 11.02.2025 · 74 (3)

DOI: 10.1007/s00262-025-03952-1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Immunology, Immunotherapy, online erschienen am 11.02.2025. Verfasst von Shuai Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China. Hauptthemen laut MEDLINE: Tertiary Lymphoid Structures, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: China Postdoctoral Science Foundation, the Youth Training Program of the Second Affiliated Hospital of the Army Medical University, Chongqing International Institute for Immunology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The influence of tertiary lymphoid structures (TLSs) on disease progression and the response to immunotherapy in head and neck squamous cell carcinoma (HNSCC) is well established, yet the heterogeneity among these structures remains largely unexplored. We utilized digital spatial profiling technology to perform in situ transcriptomic sequencing of TLSs across varying levels of maturation and distinct tumor regions within HNSCC. We assessed the prognostic significance of TLS maturation and spatial distribution in 260 patients with HNSCC through hematoxylin and eosin staining and multiplex immunohistochemistry. Furthermore, we established a TLS scoring system to predict survival in patients with HNSCC. Our study revealed that mature TLSs in the intratumor region (Intra-TLSs) of HNSCC, enriched with memory B cells, plasma cells, and CD4+ T cells, presented increased B-cell activity gene expression. Conversely, early TLSs (E-TLSs), abundant in endothelial cells, fibroblasts, and regulatory T cells, express epithelial‒mesenchymal transition (EMT)-related genes, potentially fostering tumor growth. Compared with mature TLSs within the peritumoral region (Peri-TLSs), mature Intra-TLSs have greater memory B-cell and macrophage densities and upregulate genes involved in B-cell receptor signaling and immune effector processes. Mature Peri-TLSs, characterized by endothelial cell enrichment and EMT receptor interaction genes, may contribute to tumor progression and immune evasion. Patients with mature Intra-TLSs or invasive margin TLSs (Invas-TLSs) have improved 5-year survival, whereas those with mature Peri-TLSs have poorer prognoses. By integrating TLS maturity and distribution in HNSCC, we developed a TLS scoring system to guide personalized treatments, which is crucial for predicting outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tertiary Lymphoid StructuresSquamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansPrognosisMaleFemaleMiddle AgedTumor MicroenvironmentAgedB-LymphocytesLymphocytes, Tumor-InfiltratingEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

Head and neck squamous cell carcinomaMaturation stage of TLSsSpatial distribution of TLSsTLS scoring systemTertiary lymphoid structures

Autor:innen und Institutionen

  • Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China.
  • Department of Head and Neck Surgery, The Second Affiliated Hospital, Third Military Medical University (Army Medical University), Chongqing, 400037, People's Republic of China.
  • Chongqing International Institute for Immunology, Chongqing, 400030, People's Republic of China.
  • Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China. tianyi@tmmu.edu.cn.
  • Institute of Immunology, Third Military Medical University (Army Medical University), Chongqing, 400038, People's Republic of China. wuyuzhang@iicq.vip.
  • Chongqing International Institute for Immunology, Chongqing, 400030, People's Republic of China. wuyuzhang@iicq.vip.

Förderung

  • China Postdoctoral Science Foundation
  • the Youth Training Program of the Second Affiliated Hospital of the Army Medical University
  • Chongqing International Institute for Immunology Project
  • General Program of the National Natural Science Foundation of China
  • the Special Program of the National Natural Science Foundation of China
  • Special fund for performance incentive guidance of research institutions in Chongqing
  • the Major Research Plan of the National Natural Science Foundation of China

Zitieren

APA

Xu, S., Han, C., Zhou, J., Yang, D., Dong, H., Zhang, Y., Zhao, T., Tian, Y., & Wu, Y. (2025). Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes. Cancer Immunology, Immunotherapy, 74(3). https://doi.org/10.1007/s00262-025-03952-1

Vancouver

Xu S, Han C, Zhou J, Yang D, Dong H, Zhang Y, et al. Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes. Cancer Immunology, Immunotherapy. 2025;74(3). doi:10.1007/s00262-025-03952-1

BibTeX
@article{Xu2025,
  author = {Xu, Shuai and Han, Chao and Zhou, Jian and Yang, Di and Dong, Hui and Zhang, Yiwei and Zhao, Tingting and Tian, Yi and Wu, Yuzhang},
  title = {Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes},
  journal = {Cancer Immunology, Immunotherapy},
  year = {2025},
  volume = {74},
  number = {3},
  doi = {10.1007/s00262-025-03952-1}
}
Kostenlos starten →